| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/04/2023 | ARS Pharmaceuticals, Inc. | SBTX | Sale | Common Stock | 18.9k | $7.06 | $133.5k | | 08/03/2023 |
| 08/04/2023 | ARS Pharmaceuticals, Inc. | SBTX | Exercise | Stock Option (Right to Buy) | 18.9k | $1.27 | $24k | | 08/03/2023 |
| 08/03/2023 | ARS Pharmaceuticals, Inc. | SBTX | Sale | Common Stock | 26.1k | $7.01 | $183k | | 08/03/2023 |
| 08/03/2023 | ARS Pharmaceuticals, Inc. | SBTX | Exercise | Stock Option (Right to Buy) | 26k | $1.27 | $33k | | 08/03/2023 |
| 08/02/2023 | ARS Pharmaceuticals, Inc. | SBTX | Sale | Common Stock | 36.3k | $7.09 | $257.3k | | 08/01/2023 |
| 08/02/2023 | ARS Pharmaceuticals, Inc. | SBTX | Exercise | Stock Option (Right to Buy) | 36.3k | $1.27 | $46.1k | | 08/01/2023 |
| 08/01/2023 | ARS Pharmaceuticals, Inc. | SBTX | Exercise | Stock Option (Right to Buy) | 18.7k | $1.27 | $23.8k | | 08/01/2023 |
| 08/01/2023 | ARS Pharmaceuticals, Inc. | SBTX | Sale | Common Stock | 18.7k | $7.19 | $134.6k | | 08/01/2023 |
| 07/07/2023 | ARS Pharmaceuticals, Inc. | SBTX | Sale | Common Stock | 8.9k | $6.36 | $56.4k | | 07/07/2023 |
| 07/07/2023 | ARS Pharmaceuticals, Inc. | SBTX | Exercise | Stock Option (Right to Buy) | 8.9k | $1.27 | $11.2k | | 07/07/2023 |
| 07/06/2023 | ARS Pharmaceuticals, Inc. | SBTX | Sale | Common Stock | 33.5k | $6.34 | $212.6k | | 07/03/2023 |
| 07/06/2023 | ARS Pharmaceuticals, Inc. | SBTX | Exercise | Stock Option (Right to Buy) | 33.5k | $1.27 | $42.6k | | 07/03/2023 |
| 07/05/2023 | ARS Pharmaceuticals, Inc. | SBTX | Sale | Common Stock | 31.1k | $6.41 | $199.6k | | 07/03/2023 |
| 07/05/2023 | ARS Pharmaceuticals, Inc. | SBTX | Exercise | Stock Option (Right to Buy) | 31.1k | $1.27 | $39.5k | | 07/03/2023 |
| 07/03/2023 | ARS Pharmaceuticals, Inc. | SBTX | Exercise | Stock Option (Right to Buy) | 26.5k | $1.27 | $33.7k | | 07/03/2023 |
| 07/03/2023 | ARS Pharmaceuticals, Inc. | SBTX | Sale | Common Stock | 26.5k | $6.73 | $178.3k | | 07/03/2023 |
| 06/27/2023 | ARS Pharmaceuticals, Inc. | SBTX | Grant | Stock Option (right to buy) | 40k | $6.50 | $260k | | 06/27/2023 |
| 06/02/2023 | ARS Pharmaceuticals, Inc. | SBTX | Exercise | Stock Option (Right to Buy) | 26.9k | $1.27 | $34.2k | | 06/01/2023 |
| 06/02/2023 | ARS Pharmaceuticals, Inc. | SBTX | Sale | Common Stock | 26.9k | $6.95 | $187.2k | | 06/01/2023 |
| 06/01/2023 | ARS Pharmaceuticals, Inc. | SBTX | Exercise | Stock Option (Right to Buy) | 73.1k | $1.27 | $92.8k | | 06/01/2023 |
| 06/01/2023 | ARS Pharmaceuticals, Inc. | SBTX | Sale | Common Stock | 73.1k | $6.80 | $496.8k | | 06/01/2023 |
| 05/31/2023 | Relay Therapeutics, Inc. | RLAY | Grant | Stock Option (Right to Buy) | 66.1k | $11.14 | $735.9k | | 05/31/2023 |
| 05/24/2023 | Relay Therapeutics, Inc. | RLAY | Gift | Common Stock | 12.1k | $0.00 | $0 | | 05/24/2023 |
| 05/09/2023 | ARS Pharmaceuticals, Inc. | SBTX | Exercise | Stock Option (Right to Buy) | 42.9k | $1.27 | $54.5k | | 11/09/2022 |
| 05/09/2023 | ARS Pharmaceuticals, Inc. | SBTX | Sale | Common Stock | 42.9k | $5.31 | $227.8k | | 11/09/2022 |
| 05/08/2023 | ARS Pharmaceuticals, Inc. | SBTX | Exercise | Stock Option (Right to Buy) | 57.1k | $1.27 | $72.5k | | 11/09/2022 |
| 05/08/2023 | ARS Pharmaceuticals, Inc. | SBTX | Sale | Common Stock | 57.1k | $6.16 | $351.7k | | 11/09/2022 |
| 11/09/2022 | ARS Pharmaceuticals, Inc. | SBTX | Sale | Common Stock | 43.9k | $4.58 | $201k | | 11/09/2022 |
| 08/05/2022 | ARS Pharmaceuticals, Inc. | SBTX | Exercise | Stock option (right to buy) | 78.7k | $1.27 | $100k | | 08/05/2022 |
| 06/08/2022 | Nkarta, Inc. | NKTX | Grant | Stock Option (right to buy) | 16k | $14.95 | $239.2k | | 06/08/2022 |
| 05/27/2022 | Relay Therapeutics, Inc. | RLAY | Grant | Stock Option (Right to Buy) | 41.6k | $17.33 | $720.9k | | 05/27/2022 |
| 05/02/2022 | ARS Pharmaceuticals, Inc. | SBTX | Grant | Common Stock | 68.1k | $0.00 | $0 | | 05/02/2022 |
| 05/02/2022 | ARS Pharmaceuticals, Inc. | SBTX | Grant | Stock Option (right to buy) | 136.2k | $3.15 | $429.1k | | 05/02/2022 |
| 02/01/2022 | ARS Pharmaceuticals, Inc. | SBTX | Grant | Stock Option (right to buy) | 104.5k | $4.85 | $506.8k | | 02/01/2022 |
| 02/01/2022 | ARS Pharmaceuticals, Inc. | SBTX | Grant | Stock Option (right to buy) | 165k | $4.85 | $800.2k | | 02/01/2022 |
|